Cargando…

336 Risks of COVID-19 infection and mortality for patients on biologics

Detalles Bibliográficos
Autores principales:	Pahalyants, V., Murphy, W., Klebanov, N., Theodosakis, N., Klevens, M., Lilly, E., Asgari, M., Semenov, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Patient Population Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053931/ http://dx.doi.org/10.1016/j.jid.2021.02.358

Ejemplares similares

28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study
por: Pahalyants, Vartan, et al.
Publicado: (2021)

028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts
por: Murphy, W., et al.
Publicado: (2021)

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
por: Pahalyants, Vartan, et al.
Publicado: (2022)

27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study
por: Klebanov, Nikolai, et al.
Publicado: (2021)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts
por: Murphy, William, et al.
Publicado: (2021)

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Klebanov, Nikolai, et al.
Publicado: (2021)

281 Racial and language disparities in teledermatology visits for acne during the COVID-19 pandemic
por: Lee, M.S., et al.
Publicado: (2021)

255 The risk of contracting COVID-19 after dermatological procedures compared with other medical procedures
por: Raiker, R., et al.
Publicado: (2021)

342 Clinical outcomes in COVID-19 patients with Atopic dermatitis
por: Pakhchanian, H., et al.
Publicado: (2021)

338 Clinical outcomes in COVID-19 patients with dermatopolymyositis
por: Pakhchanian, H., et al.
Publicado: (2021)

254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients
por: Raiker, R., et al.
Publicado: (2021)

335 Trends in dermatological prescribing patterns during the COVID pandemic
por: Pakhchanian, H., et al.
Publicado: (2021)

332 National trends of dermatology procedures during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

243 Clinical outcomes in COVID-19 patients with varicella zoster virus
por: Raiker, R., et al.
Publicado: (2021)

331 Trends and outcomes in patients with malignant skin cancers during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

391 Public sunscreen dispensers and consumer sunscreen trends during the COVID-19 pandemic
por: Maghfour, J., et al.
Publicado: (2021)

381 Perspective of psoriatic disease patients on novel COVID-19 vaccines
por: Gondo, G., et al.
Publicado: (2021)

336. Characteristics of Acute Bacterial Meningitis and Predictors of Mortality
por: Nimitvilai, Sireethorn, et al.
Publicado: (2018)

336. COVID-19 and Pneumocystis jiroveci Pneumonia
por: Saling, Christopher, et al.
Publicado: (2021)

Protecting against COVID-19
por: Mark, Anita M.
Publicado: (2021)

Dental care during the COVID-19 pandemic
por: Mark, Anita M.
Publicado: (2020)

Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019)

Statins are associated with a large reduction in all-cause mortality in women from a cardiac outpatient population
por: Bots, Sophie H, et al.
Publicado: (2022)

336. Developing a Protein Signature of Early Latent Tuberculosis Infection.
por: Bark, Charles, et al.
Publicado: (2022)

Prevalence of cardiac pathology and relation to mortality in a multiethnic population hospitalised with COVID-19
por: Bioh, Gabriel, et al.
Publicado: (2021)

Cardiovascular disease recurrence and long-term mortality in a tri-ethnic British cohort
por: Vyas, Manav V, et al.
Publicado: (2021)

Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK
por: Lyons, Jane, et al.
Publicado: (2022)

The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
por: Abrouk, Michael, et al.
Publicado: (2016)

The population bomb /
por: Ehrlich, Paul R.
Publicado: (1995)

Biologically meaningful coverage indicators for eliminating malaria transmission
por: Kiware, Samson S., et al.
Publicado: (2012)

Returning to good health care can start with a smile
por: Mark, Anita M.
Publicado: (2022)

Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
por: Omland, Torbjorn, et al.
Publicado: (2021)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
por: Stevenson, Alex, et al.
Publicado: (2020)

Effects of paediatric HIV infection on electrical conduction of the heart
por: Idris, Nikmah S, et al.
Publicado: (2016)

Evaluating the role of transthoracic echocardiography in hospitalised patients with COVID-19 infection
por: Babu, Aswin, et al.
Publicado: (2022)

Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan
por: Kusuda, Satoshi, et al.
Publicado: (2012)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uel6jfbjjmarpor1oh3agnmq3l